Results 121 to 130 of about 893,284 (261)

A Multidisciplinary Approach as a Goal for the Management of Complications in Systemic Scleroderma: A Literature Review and Case Scenario. [PDF]

Diagnostics (Basel), 2023
Pătrîntașu DE, Sárközi HK, Lupușor E, Vlangăr IE, Rotariu GM, Rența IA, Nan AN, Budin CE.   +7 more
europepmc   +1 more source

[Systemic sclerosis (scleroderma) without scleroderma].

Likars'ka sprava, 2002
There are two approaches toward dealing with systemic sclerosis (scleroderma) presenting with no skin involvement. According to one of these the condition is to be treated as atypical systemic sclerosis (scleroderma). With the other approach it does not make much difference whether systemic sclerosis presents with skin involvement or not.
openaire   +1 more source

Immune checkpoint inhibitor‐induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn, Alexandre O. Gérard, Maëlys Labat, Zoe Apalla, Wouter van Binsbergen, Dimitra Koumaki, Valerian Rivet, Frederic Dezoteux, Damien Giacchero, Michael R. Ardern‐Jones, Kara Heelan, Jesse P. Hirner, Ander Mayor, Mariette Labots, Markus V. Starink, Conny J. van der Laken, Vincent Sibaud, Yannick S. Elshot   +17 more
wiley   +1 more source

The Importance OF Secondary Prevention in Systemic Scleroderma

, 2023
Systemic scleroderma is a multisystemic disease involving skin and internal organs (gastrointestinal tract, lungs, heart, kidneys, and peripheral nervous system).
Rakhimov, S. S. (Sardor), Akhmedov, K. S. (Khalmurad), Buranova, S. N. (Sagdiyana)   +2 more
core  

Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysis

Background: Interstitial lung disease is the leading cause of morbidity and mortality in systemic sclerosis, but it is characterized by significant heterogeneity in patient outcomes. So far, little is known about the influence of anti-U1RNP antibodies on
Launay, David, Airo, Paolo, B?l?nescu, Andra Rodica, Distler, Oliver, Boleto, Goncalo, Bergmann, Christina, Campochiaro, Corrado, Airo’, Paolo, Balanescu, Andra   +8 more
core   +1 more source

The Process of Identity Management in Individuals Living with Systemic Scleroderma [PDF]

, 2020
The Process of Identity Management in Individuals Living with Systemic Scleroderma Background: People with chronic illnesses may struggle to adapt psychologically to the illness experience and have feelings of identity loss, self-diminishment, and ...
Miller, Donald David
core  

Diffuse Skin Sclerosis in a Patient With Lung Cancer

JEADV Clinical Practice, EarlyView.
Anna‐Sophia Leven, Eva Hadaschik, Alpaslan Tasdogan   +2 more
wiley   +1 more source

Restoring Mouth Opening in Systemic Sclerosis: A Scoping Review of Interventions

Oral Diseases, EarlyView.
ABSTRACT Objectives To map and characterize the therapeutic strategies described in the literature for the management of microstomia in patients with systemic sclerosis. Methods This scoping review was conducted in accordance with the PRISMA‐ScR guidelines. Searches were performed in Medline/PubMed, Embase, Scopus, Web of Science, Cochrane Library, and
Beatriz Borba Barros Bernardo, Lucas Nascimento Ribeiro, Luiz Alcino Monteiro Gueiros, Belmiro Cavalcanti do Egito Vasconcelos, Sandra Lúcia Dantas Moraes, Marianne Vasconcelos Carvalho   +5 more
wiley   +1 more source

Acute limb ischemia in an adolescent with COVID-19 and systemic scleroderma: a case report. [PDF]

BMC Pediatr, 2022
Milan MJDC, Dans LF, Torres-Ticzon VMF.
europepmc   +1 more source

CARDIAC INVOLVEMENT IN IRAQI PATIENTS WITH SYSTEMIC SCLEROSIS (SCLERODERMA).

, 2018
Background: Systemic sclerosis (Scleroderma) is a chronic multisystem disease of unknown etiology, has been considered a disease of metabolic disorder of connective tissue. Methodology: A case control study.
Mustafa Al-Izzi., Mohammed Ali Al-shammari   +1 more
core   +1 more source